MOA - PK Overview George F. Koob, Ph.D.

Slides:



Advertisements
Similar presentations
The Addicted Synapse Katie Malanson.
Advertisements

OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES
OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES
E.4 Neurotransmitters and Synapses. E4.1 Postsynaptic Responses Pre-synaptic neurons can inhibit or excite the post synaptic neuron by releasing excitatory.
Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self- Administration in Withdrawn, Ethanol Dependent.
09-Sep-2003 Predicting human risk with animal research: lessons learned from caffeine/ephedrine combinations Richard J. Briscoe, Ph.D. Safety Pharmacology.
Nicotine and Caffeine Chapter 12. Leaves of the Nicotiana tabacum plant Nicotine History.
Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.
Part Fundamentals of Physiology Part II Food, Energy, and Temperature Part III Integrating systems Part IV Movement and Muscle Part V Oxygen, Carbon dioxide,
Journal Club Alcohol and Health: Current Evidence July-August 2006.
Neurobiology of drug action and
ANTICONVULSANT DRUGS Edward D. French, Ph.D. Department of Pharmacology University of Arizona College of Medicine.
Drugs, Addiction and Reward. Stimulants Behavioral Effect: increase activity, arousal, excitement, etc. Primary Mechanism of Action: Activation of D2-D4.
Alcohol and Stress Hormones
Copyright Alcohol Medical Scholars Program1 Alcohol: Pharmacology and Neurobiology Vijay A. Ramchandani, Ph.D. Indiana University School of Medicine.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Biological Psychology
Drug Tolerance Cross Tolerance Metabolic Tolerance
Psychopharmacology The Study of the effects of drugs on the nervous system and behavior Drugs: – Exogenous chemical (not produced by the body) – Not necessary.
Chapter 9 Alcohol Acute effects Mechanisms of action Long-term effects
Questions 17-1 Q: What happens to a nerve impulse once it reaches the end of an axon? Q: How does one neuron communicate with another?
Information prepared by Eisai Europe Ltd
Lynda Sharrett-Field Addiction Therapy-2014 Chicago, USA August 4 - 6, 2014.
Chapter Four Psychopharmacology Version Dated 21 Sep 2009.
Alcohol Dr Alison Battersby.
Multiple Neuronal Systems Thought to be Involved in Nicotine Dependence Frank Vocci, Ph.D. Director Division of Treatment Research and Development National.
Gender Differences in Alcohol and Drug Response
Molecular mechanisms of memory. How does the brain achieve Hebbian plasticity? How is the co-activity of presynaptic and postsynaptic cells registered.
E4 Neurotransmitters and synapses
Psychopharmacology (psychoactive drugs)
Properties of Memantine and Mechanism of Action
Stress and Drug Abuse Primary interaction of stress and drug abuse is relapse. Can stress cause initiation of drug use/abuse?
Role of Interleukin-1 System in Alcohol Drinking and Preference 3rd International Conference and Exhibition on Clinical & Cellular Immunology September.
Synaptic Transmission
Upload “Neurotransmitters and Drugs” To eBackpack.
Neuro Unit 5: How do our choices change our brains?
Neurological Disorders Lesson 5.2 How do drugs alter synaptic transmission? Human Brain Rat Brain.
Metabotropic Glutamate 5 Receptors: Role in drug self-administration and in regulating the activity of brain reward systems Paul J. Kenny, Ph.D The Scripps.
Nicotine and Caffeine Chapter 12. Leaves of the Nicotiana tabacum plant Nicotine History.
 A synapse divides at least 2 (usually more) neurons by ~20nm.  Presynaptic Neurons: carry impulses to the synapse  Postsynaptic Neurons: carry impulses.
Drug addiction – learning gone wild? Dr Stuart McLaren MRCPsych. Phase 1 Psychopharmacology module
Tipsy Neurons Jackie Barlow Joseph Esdin Trish Hartzell Kalyani Maitra Miriam Martin Xia Yang & Jim Burnette.
SYNAPTIC & NEUROMUSCULAR TRANSMISSION Ass. Prof. Dr. Emre Hamurtekin EMU Faculty of Pharmacy.
Graduate Seminar, NJIT June 14, 2012 Analytical & Computational Neuroscience: Lecture 2 Action Potentials and Chemical Synapses Math 430 * Math 635 * Fall.
Trends in Biomedical Science Making Memory. The following slides are mostly derived from The Brain from Top to Bottom, an Interactive Website about the.
Neurotransmitters A. Criteria 1. must mimic presynaptic effects if administered exogenously 2. must be released during activity of presynaptic neuron 3.
Shailesh P. Banerjee, Christopher Y. Chan & Eitan Friedman
University of Jordan1 Physiology of Synapses in the CNS- L4 Faisal I. Mohammed, MD, PhD.
Synaptic Transmission / Central Synapses I Tom O’Dell Department of Physiology C8-161 (NPI), x64654.
The clinical usefilness of Tianeptine on Alcohol dependence
알코올 의존, 질병의 경과와 항갈망제의 사용 Industry-sponsored lecture 알코올 의존, 질병의 경과와 항갈망제의 사용 Ki, Seon Wan M.D., Ph. D. Incheon St. Mary’s Hospital Incheon, Korea.
Ch 8. Synaptic Plasticity 8.9 ~ 8.10 Adaptive Cooperative Systems, Martin Beckerman, Summarized by Kim, S. –J. Biointelligence Laboratory, Seoul.
Experiment 1 – Graded Dose-Response Curve
Exam 2 3/30/16 Range: Average: 79.8 Exam 1 2/17/16 Range: 49-98
Long Term Potentiation
Unit IV Lesson III, Activity I
ANTI-SEIZURE MEDICATIONS
Neurotransmitters.
Drugs that activate Gio-proteins receptors
Basic Principles of Neuropharmacology
Neurotransmitters What is a neurotransmitter?
A.5 Neuropharmacology.
Corticotropin-Releasing Factor in the BNST
Neuroscience of Addiction
Alcohol Use Disorder Assessment & Treatment Strategies
Lithium: Mechanism of Action
P.P. De Deyn, R. Vanholder, R. D'Hooge
Neurobiology/ Behavior Lesson
Design Issues in Human studies of Psychopharmacology placebo controls double blind studies.
Presentation transcript:

MOA - PK Overview George F. Koob, Ph.D. KO - Koob 4/22/2017 MOA - PK Overview George F. Koob, Ph.D. Professor, Department of Neuropharmacology Director, Division of Psychopharmacology The Scripps Research Institute

KO - Koob 4/22/2017 Acamprosate

KO - Koob 4/22/2017

Stages of Alcoholism Important for the Development of Animal Models KO - Koob 4/22/2017 Stages of Alcoholism Important for the Development of Animal Models Acute Reinforcement/Social Drinking Escalating/Compulsive Use Binge Drinking Genetic variables Environmental factors Stress Conditioning effects Dependence Relapse Withdrawal Protracted Withdrawal Recovery?

Effects of Acamprosate on Animal Models of Excessive Drinking KO - Koob 4/22/2017 Effects of Acamprosate on Animal Models of Excessive Drinking Acamprosate decreases alcohol drinking in rats selected for excessive drinking (Boismare et al., 1984) Acamprosate decreases alcohol intake in dependent rats (Le Magnen, Tran, Durlach and Martin, 1987) Acamprosate reverses the preference for alcohol and the increase in drinking in dependent rats during withdrawal (Geiss, Heidbreder, Opsomer, Durbin and De Witte, 1991; Morse and Koob, unpublished results) Acamprosate eliminates the alcohol deprivation effect in rats under free-drinking continuous access or operant limited access conditions (Spanagel, Holter, Allingham, Landgraf and Zieglgansberger, 1996; Holter, Landgraf, Zieglgansberger and Spanagel, 1997; Heyser, Schulteis, Durbin and Koob, 1998)

KO - Koob 4/22/2017 Protocol for Initiation of Lever Pressing for Oral Ethanol Self-Administration in the Rat Training Saccharin (w/v) EtOH (w/v) Days Day 1-3 4-9 10 11-12 13 14 15-16 17 18+ 0.2% - 0% 5% 8% 10%

KO - Koob 4/22/2017 Blood Alcohol Levels in a Free-Choice Operant Task for Ethanol (10%) and Water Following the Saccharin Fade Out Procedure From: Rassnick S, Pulvirenti L and Koob GF, Alcohol, 1993, 10:127-132.

Effects of Abstinence Interval on Alcohol Self-Administration KO - Koob 4/22/2017 Effects of Abstinence Interval on Alcohol Self-Administration From: Heyser CJ, Schulteis G, Durbin P and Koob GF, Neuropsychopharmacology, 1998, 18:125-133.

KO - Koob 4/22/2017 Chronic Acamprosate on Responding for Ethanol Following 5 Days Abstinence From: Heyser CJ, Schulteis G, Durbin P and Koob GF, Neuropsychopharmacology, 1998, 18:125-133.

What Acamprosate Does Not Do in Animal Models KO - Koob 4/22/2017 What Acamprosate Does Not Do in Animal Models Acamprosate does not produce anti-conflict effects in an animal model of anxiety (Koob and Britton, unpublished results) Acamprosate does not substitute for alcohol in drug discrimination (Spanagel, Zieglgansberger and Hundt, 1996) Acamprosate does not block the discriminative stimulus properties of alcohol (Spanagel, Zieglgansberger and Hundt, 1996) Acamprosate does not have any reinforcing effects or aversive effects on its own (Grant and Woolverton, 1989; Morse and Koob, unpublished results) Acamprosate does not antagonize the discriminative stimulus effects of amphetamine or morphine, or the reinforcing effects of heroin (Pascucci et al., 1999; Spanagel et al., 1998)

KO - Koob 4/22/2017 Schematic Neuron Showing the Possible Mode of Action of Acamprosate on Alcohol-Related Effects From: Spanagel R and Zieglgansberger W, Trends Pharmacol Sci, 1997, 18:54-59.

Neuropharmacological Effects of Acamprosate KO - Koob 4/22/2017 Neuropharmacological Effects of Acamprosate Acamprosate inhibits neuronal hyperexcitatability by decreasing presynaptic release of the excitatory neurotransmitter glutamate and by decreasing post-synaptic excitability of glutamate receptors (Zeise, Kaparaov, Capogna and Ziegelgansberger, 1993; Dahchour et al., 1998; Koob, Mason, De Witte, Littleton and Siggins, 2002) Acamprosate inhibits calcium influx through NMDA glutamate receptors through an interaction with polyamines on the NMDA receptor (Naassila, Hammoumi, Legrand, Durbin and Daoust, 1998; al-Qatari, Bouchenafa and Littleton, 1998; Popp and Lovinger, 2000) Acamprosate inhibits calcium influx through voltage-dependent calcium channels (al-Qatari and Littleton, 1995; Allgaier, Franke, Dobottka and Scheibler, 2000) Acamprosate increases synaptic availability of the inhibitory neurotransmitter taurine (Dahchour, Quertemont and De Witte, 1996) KoobG/NP/wor4/031902jh

Functional Significance of the Neuropharmacological Mechanism of Action of Acamprosate Acamprosate acts as a partial co-agonist at the glutamate receptor through an allosteric interaction with the polyamine binding site on the NMDA glutamate receptor complex Neuropharmacological consequences are to enhance activation of the glutamate receptor when levels of endogenous activators are low, but inhibit activation when levels of endogenous activators are high (such as during alcohol withdrawal)

Neuroprotective Effects of Acamprosate KO - Koob 4/22/2017 Neuroprotective Effects of Acamprosate Acamprosate is neuroprotective against glutamate-induced neurotoxicity when enhanced by alcohol withdrawal in neocortical cultures of fetal rat brain (al Qatari, Khan, Harris and Littleton, 2001) Acamprosate reduces excitatory postsynaptic field potentials in the hippocampus which may lead to protection against hyperexcitability such as epileptiform activity and seizures (Koob, Mason, De Witte, Littleton and Siggins, 2002) Acamprosate decreases neurological deficits associated with cerebral ischemia in the rat (Engelhard, Werner, Lu, Mollenberg and Zieglgansberger, 2000) Acamprosate decreases the severe mortality associated with alcohol withdrawal in the rat (Dahchour, Landron and De Witte, 2001) Acamprosate normalizes sleep changes induced by alcohol and produces some cognitive-enhancing effects in healthy human volunteers (Koob, Mason, De Witte, Littleton and Siggins, 2002)

Pre-Clinical and Clinical Pharmacokinetics of Acamprosate Animal Human Bioavailability 16% - rats 11% Elimination Half-life 23-31 hours - rats 18 hours Time to Steady State 5-7 days 5-7 days Plasma Levels Protein Binding None None Elimination Not metabolized Not metabolized Renal excretion Renal excretion Lethality 6 grams/kg No known lethality

Drug Interactions with Acamprosate Animal Human Alcohol None None Disulfiram None None Anticonvulsants None N/A Anxiolytics None None Antipsychotics None N/A Antidepressants None None Naltrexone N/A Plasma acamprosate

KO - Koob 4/22/2017 Schematic Neuron Showing the Possible Mode of Action of Acamprosate on Alcohol-Related Effects From: Spanagel R and Zieglgansberger W, Trends Pharmacol Sci, 1997, 18:54-59.